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 Abstract
Dexamethasone, a corticosteroid that inhibits the release of substances in the body that cause inflammation, is commonly used for the treatment of arthritis. However, glucocorticoid-induced osteoporosis is a side effect that commonly 
occurs after dexamethasone treatment. One of the mechanisms in which glucocorticoids is thought to suppress bone formation is through their effect on the wnt/β-catenin signaling pathway. The wnt/β-catenin pathway is essential in the 
formation of new osteoblasts and the prevention of current osteoblast apoptosis. However, treatment with dexamethasone is thought to destabilize and inhibit nuclear translocation of β-catenin, decreasing the survival of osteoblasts.1 By 
using precursor mouse osteoblast MC3T3 cells, antisense collagen 11 is analyzed as a potential treatment to reverse the detrimental effects of dexamethasone on the wnt signaling pathway. MC3T3 cells are exposed to dexamethasone  in 
vitro, then aspects of the wnt pathway and collagen system are studied in depth. 
Background and Objective
• To analyze the inhibition of Collagen 11 and if it stimulates a 
compensatory system leading to extra Collagen V and I production.  
• Antisense Collagen 11 is studied to be used as a potential treatment to 
reverse osteoporosis through wnt/β-catenin pathway (Fig. 2).5 
Figure 1 Decrease in osteoblast productivity leads to osteoporosis and bone damage.2 
 Molecular Mechanism
Figure 2 shows the hypothesized 
process of siRNA Col11a1 insertion, 
inhibition of Collagen XI expression, 
and wnt pathway progression 
through LRP-1 receptor. 3 4
 Experimental Setup
Figure 3 shows the well treatments. Wells 1-3 are experimental with 
an addition of siRNA Collagen XI. Wells 4-6 are control without the 
addition of Collagen XI morpholino, but with control siRNA. 
● MC3T3, mouse precursor osteoblast cells, were  passaged into 
a 6-well plate. (215,3488 cells/well.) 
● After one day of incubation, beta-glycerophosphate and 
ascorbic acid were added (100 µg/mL and 10 mM working 
concentrations respectively) to induce cell differentiation. 
● After incubating for 6 days, 1mL of Opti-MEM media and 50µM 
of Dexamethasone were added to both experimental and 
control.6 The wells were treated with endoporter and their 
specific morpholino as shown in Figure 3. The 6-well plate was 
incubated for 24 hours. 
● Media solution was replaced with 3 mL of DMEM + 10% FBS + 
1% P/S and incubated for 24 hours. 
● qRT-PCR was performed, and microscopy images were taken. 
Cell Images
Control Experimental 
Figure 4 Pictures of each well were taken using the confocal lens 
after being treated with dexamethasone (50µM) and morpholino 
(12µM) for 48 hours. In well #2 and #3, there are less dense areas 
leading to believe our treatment affected our cells. 
RT-PCR Analysis
• qRT-PCR used to identify 
expression of genes. Data 
was normalized via house 
keeping genes (HKG.) Fold 
change and relative 
abundance data provided.  
• Overall, results show an 
increase in Collagen type 1 
and V (Fig. 7) production 
and an increase in 
expression of MMP-13 
(Fig. 6) and β-catenin (Fig. 
5) in experimental cells. 
• Transmitted light 
microscopy images were 
taken to depict any 
differences in osteoblast 
confluency and 
morphology. 
Figure 5 shows the relative abundance of 
Ctnnb1, with a large increase in the 
experimental group. 
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Figure 6 shows the relative abundance of 
Mmp13, with a large increase in the 
experimental group. 
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Figure 7  Shows the fold change (increase of 
gene expression) for both Collagen I and V. 
The increase of these genes explain the 
results of knocking down collagen XI.
 Discussion
Research Findings
• qRT-PCR analysis shows significant compensatory production of Collagen V and I in response to Collagen XI knockdown that 
shows promotion of osteoblast formation and mineralization (Fig. 4). 
• MMP-13 and β-catenin are overexpressed in experimental cells (Fig. 5) showing progression of the wnt/β-catenin pathway 
illustrated in Fig. 1.3 
○ Leads to cell proliferation and an increase in bone density. 
• Microscope figures show significant similarity in morphology between experimental and control MC3T3 osteoblasts. 
Possible Future Research
• Analyze the expression of Collagen XI using RT-PCR to ensure knockdown of Coll11a1 using siRNA. 
○ Study MMP-13 and β-catenin expression after knockdown verification. 
• Investigate the relationship between Collagen type 1 and V and the compensatory process occurring during Collagen type XI 
knockdown.  
• While the data portrayed in this experiment is relevant to human cell functioning, future research with a human cell line 
must be done to successfully correlate our findings to human processes.
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